Bisphosphonates in prostate cancer: where are we and where should we go?
- PMID: 12953073
- DOI: 10.1093/jnci/djg062
Bisphosphonates in prostate cancer: where are we and where should we go?
Comment in
-
Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.J Natl Cancer Inst. 2003 Sep 3;95(17):1273-4. doi: 10.1093/jnci/95.17.1273. J Natl Cancer Inst. 2003. PMID: 12953081 No abstract available.
Comment on
-
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).J Natl Cancer Inst. 2003 Sep 3;95(17):1300-11. doi: 10.1093/jnci/djg038. J Natl Cancer Inst. 2003. PMID: 12953084 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
